The DOI matches its Crossref record; 101 of the 109 references it cites were found in a registry or an index, and 8 are not checked yet.
Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications.
Open accessAbstract
Extensively characterized, modified, and employed for a variety of purposes, adenovirus (Ad) vectors are generally regarded as having great potential by many applied virologists who wish to manipulate and use viral biology to achieve beneficial clinical outcomes. Despite widespread functional prominence and utility (i.e., Ad-based clinical trials have begun to progress to critical Phase III levels, it has recently become apparent that investigations regarding the innate immune response to Ads may reveal not only reasons behind previous failures, but also reveal novel insights that will allow for safer, more efficacious uses of this important gene transfer platform. Insights gained by the exploration of Ad induced innate immune responses will likely be most important to the fields of vaccine development, since Ad-based vaccines are regarded as one of the more promising vaccine platforms in development today. Adenovirus is currently known to interact with several different extracellular, intracellular, and membrane-bound innate immune sensing systems. Past and recent studies involving manipulation of the Ad infectious cycle as well as use of different mutants have shed light on some of the initiation mechanisms underlying Ad induced immune responses. More recent studies using microarray-based analyses, genetically modified cell lines and/or mouse mutants, and advanced generation Ad vectors have revealed important new insights into the scope and mechanism of this cellular defensive response. This review is an attempt to synthesize these studies, update Ad biologists to the current knowledge surrounding these increasingly important issues, as well as highlight areas where future research should be directed. It should also serve as a sobering reality to researchers exploring the use of any gene transfer vector, as to the complexities potentially involved when contemplating use of such vectors for human applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“however, antigen non-specific stimulation of type I interferon pathways has been demonstrated with other formulations of mRNA in animal models78,79.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
Phylogenetic Perspectives in Innate Immunity
Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., & Ezekowitz, R. A. B. (1999) · Science · doi:10.1126/science.284.5418.1313 · Cited by 2,524
Decoding the Patterns of Self and Nonself by the Innate Immune System
Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154
VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling
Xu, L., Wang, Y., Han, K.-J., Li, L., Zhai, Z., & Shu, H. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.014 · Cited by 1,849
Innate immune sensing and its roots: the story of endotoxin
Beutler, B., & Rietschel, E. (2003) · Nature reviews. Immunology · doi:10.1038/nri1004 · Cited by 1,392
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.010 · Cited by 1,368
Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells
Lund, J. M., Sato, A., Akira, S., Medzhitov, R. M., & Iwasaki, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030162 · Cited by 1,197
Gitlin, L., Barchet, W., Gilfillan, S., Cella, M., Beutler, B., Flavell, R. A., Diamond, M., & Colonna, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603082103 · Cited by 1,177
Multiple-laboratory comparison of microarray platforms
Irizarry, R. A., Warren, D., Spencer, F., Kim, I. F., Biswal, S., Frank, B. C., Gabrielson, E., Garcia, J. G. N., Geoghegan, J., Germino, G., et al. (2005) · Nature Methods · doi:10.1038/nmeth756 · Cited by 862
Signaling Pathways Downstream of Pattern-Recognition Receptors and Their Cross Talk
Lee, M. S., & Kim, Y. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060605.122847 · Cited by 781
A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA
Ishii, K. J., Coban, C., Kato, H., Takahashi, K., Torii, Y., Takeshita, F., Ludwig, H., Sutter, G., Suzuki, K., Hemmi, H., et al. (2005) · Nature Immunology · doi:10.1038/ni1282 · Cited by 771
Parks, R. J., Chen, L., Anton, M., Sankar, U., Rudnicki, M. A., & Graham, F. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13565 · Cited by 725
Evaluation of gene expression measurements from commercial microarray platforms
Tan, P. K. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg763 · Cited by 705
Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2
Compton, T., Kurt‐Jones, E. A., Boehme, K. W., Belko, J., Latz, E., Golenbock, D. T., & Finberg, R. W. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4588-4596.2003 · Cited by 676
The Specific and Essential Role of MAVS in Antiviral Innate Immune Responses
Sun, Q., Sun, L., Liu, H.-H., Chen, X., Seth, R. B., Forman, J., & Chen, Z. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.04.004 · Cited by 604
Type I interferons produced by dendritic cells promote their phenotypic and functional activation
Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P., & Tough, D. F. (2002) · Blood · doi:10.1182/blood.v99.9.3263 · Cited by 534
Hemagglutinin Protein of Wild-Type Measles Virus Activates Toll-Like Receptor 2 Signaling
Bieback, K., Lien, E., Klagge, I. M., Avota, E., Schneider‐Schaulies, J., Duprex, W. P., Wagner, H., Kirschning, C. J., ter Meulen, V., & Schneider‐Schaulies, S. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8729-8736.2002 · Cited by 516
Essential role of IPS-1 in innate immune responses against RNA viruses
Kumar, H., Kawai, T., Kato, H., Sato, S., Takahashi, K., Coban, C., Yamamoto, M., Uematsu, S., Ishii, K. J., Takeuchi, O., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060792 · Cited by 503
Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus
Haynes, L. M., Moore, D. D., Kurt‐Jones, E. A., Finberg, R. W., Anderson, L. J., & Tripp, R. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10730-10737.2001 · Cited by 496
Murine retroviruses activate B cells via interaction with toll-like receptor 4
Rassa, J., Meyers, J., Zhang, Y., Kudaravalli, R., & Ross, S. (2002) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.042355399 · Cited by 493
Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration
Worgall, S., Wolff, G., Falck-Pedersen, E., & Crystal, R. G. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-37 · Cited by 487
Muruve, D. A., Barnes, M. J., Stillman, I. E., & Libermann, T. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950018364 · Cited by 447
Molecular basis of the inflammatory response to adenovirus vectors
Liu, Q., & Muruve, D. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302036 · Cited by 430
Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity
Shayakhmetov, D. M., Gaggar, A., Ni, S., Li, Z.-Y., & Lieber, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7478-7491.2005 · Cited by 429
Means, T. K., Hayashi, F., Smith, K. D., Aderem, A. A., & Luster, A. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5165 · Cited by 416
Lieber, A., He, C. Y., Meuse, L., Schowalter, D., Kirillova, I., Winther, B., & Kay, M. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8798-8807.1997 · Cited by 411
O’Riordan, C. R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S. C., Smith, A. E., & Francis, G. E. (1999) · Human Gene Therapy · doi:10.1089/10430349950018021 · Cited by 409
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
Krieg, A. Μ., Wu, T., Weeratna, R. D., Efler, S. M., Love-Homan, L., Yang, L., Yi, A., Short, D., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12631 · Cited by 396
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors
Zaiss, A.-K., Liu, Q., Bowen, G. P., Wong, N. C. W., Bartlett, J. S., & Muruve, D. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4580-4590.2002 · Cited by 394
Zhu, J., Huang, X., & Yang, Y. (2007) · Journal of Virology · doi:10.1128/jvi.02192-06 · Cited by 370
A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.
Ginsberg, H. S., Moldawer, L. L., Sehgal, P. B., Redington, M., Kilian, P. L., Chanock, R. M., & Prince, G. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1651 · Cited by 353
Tao, N., Gao, G., Parr, M. J., Johnston, J., Baradet, T. C., Wilson, J. M., Barsoum, J., & Fawell, S. E. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0227 · Cited by 321
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
Jooss, K. U., & Chirmule, N. B. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302037 · Cited by 278
Löser, P., Jennings, G. S., Strauss, M., & Sandig, V. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.180-190.1998 · Cited by 277
Comprehensive comparison of six microarray technologies
Yauk, C. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh123 · Cited by 244
Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines
Applequist, S. E. (2002) · International Immunology · doi:10.1093/intimm/dxf069 · Cited by 238
Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression
Bruder, J. T., & Kovesdi, I. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.398-404.1997 · Cited by 230
Adenovirus Serotype 5 Fiber Shaft Influences In Vivo Gene Transfer in Mice
Smith, T. A., Idamakanti, N., Rollence, M. L., Marshall-Neff, J., Kim, J., Mulgrew, K. A., Nemerow, G. R., Kaleko, M., & Stevenson, S. C. (2003) · Human Gene Therapy · doi:10.1089/104303403765255165 · Cited by 215
Einfeld, D. A., Schroeder, R., Roelvink, P. W., Lizonová, A., King, C. R., Kovesdi, I., & Wickham, T. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11284-11291.2001 · Cited by 213
Shayakhmetov, D. M., Li, Z.-Y., Ni, S., & Lieber, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5368-5381.2004 · Cited by 210
Shi, L. M., Tong, W., Fang, H., Scherf, U., Han, J., Puri, R. K., Frueh, F. W., Goodsaid, F. M., Guo, L., Su, Z., et al. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-s2-s12 · Cited by 201
Trevejo, J., Marino, M. W., Philpott, N. J., Josien, R., Richards, E. C., Elkon, K. B., & Falck-Pedersen, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211423598 · Cited by 198
High Efficiency Adenovirus-Mediated Gene Transfer to Human Dendritic Cells
Dietz, A. B., & Vuk‐Pavlović, S. (1998) · Blood · doi:10.1182/blood.v91.2.392.392_392_398 · Cited by 193
The influence of adenovirus fiber structure and function on vector development for gene therapy
Nicklin, S. A., Wu, E. Y., Nemerow, G. R., & Baker, A. H. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.05.008 · Cited by 185
Ustaçelebi, S., & Williams, J. (1972) · Nature · doi:10.1038/235052a0 · Cited by 181
Stone, D., Liu, Y., Shayakhmetov, D. M., Li, Z.-Y., Ni, S., & Lieber, A. (2007) · Journal of Virology · doi:10.1128/jvi.02819-06 · Cited by 169
Croyle, M. A., Chirmule, N. B., Zhang, Y., & Wilson, J. M. (2002) · Human Gene Therapy · doi:10.1089/104303402760372972 · Cited by 165
Morral, N., O’Neal, W. K., Rice, K., Leland, M. M., Piedra, P. A., Aguilar-Córdova, E., Carey, K. D., Beaudet, A. L., & Langston, C. (2002) · Human Gene Therapy · doi:10.1089/10430340152712692 · Cited by 163
Nociari, M., Ocheretina, O., Schoggins, J. W., & Falck-Pedersen, E. (2007) · Journal of Virology · doi:10.1128/jvi.02685-06 · Cited by 159
Cheng, G., Zhong, J., Chung, J., & Chisari, F. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703285104 · Cited by 158
Zsengellér, Z. K., Otake, K., Hossain, S.-A., Berclaz, P., & Trapnell, B. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9655-9667.2000 · Cited by 156
Santra, S., Seaman, M. S., Xu, L., Barouch, D. H., Lord, C. I., Lifton, M. A., Gorgone, D. A., Beaudry, K. R., Svehla, K., Welcher, B. C., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6516-6522.2005 · Cited by 149
Schiedner, G., Hertel, S., Johnston, M., Dries, V., van Rooijen, N., & Kochanek, S. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00017-5 · Cited by 148
The Role of Capsid–Endothelial Interactions in the Innate Immune Response to Adenovirus Vectors
Liu, Q., Zaiss, A. K., Colarusso, P., Patel, K. D., Haljan, G. J., Wickham, T. J., & Muruve, D. A. (2003) · Human Gene Therapy · doi:10.1089/104303403321618146 · Cited by 146
Toll-like Receptor 9 Triggers an Innate Immune Response to Helper-dependent Adenoviral Vectors
Cerullo, V., Seiler, M. P., Mane, V. P., Brunetti‐Pierri, N., Clarke, C., Bertin, T., Rodgers, J. R., & Lee, B. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300031 · Cited by 143
López, C. B., Moltedo, B., Alexopoulou, L., Bonifaz, L. C., Flavell, R. A., & Moran, T. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6882 · Cited by 143
Smith, T. A., Idamakanti, N., Marshall-Neff, J., Rollence, M. L., Wright, P., Kaloss, M., King, L., Mech, C. A., Dinges, L., Iverson, W. O., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403322542248 · Cited by 138
Hartman, Z. C., Kiang, A., Everett, R., Serra, D. M., Yang, X. Y., Clay, T. M., & Amalfitano, A. (2006) · Journal of Virology · doi:10.1128/jvi.01936-06 · Cited by 136
Self-citationBorgland, S. L., Bowen, G. P., Wong, N. C. W., Libermann, T. A., & Muruve, D. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.3941-3947.2000 · Cited by 135
Complement activation by recombinant adenoviruses
Cichon, G., Boeckh-Herwig, S., Schmidt, H., Wehnes, E., Müller, T. H., Pring‐Åkerblom, P., & Burger, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301611 · Cited by 128
Yang, R., Murillo, F., Cui, H., Blosser, R. L., Uematsu, S., Takeda, K., Akira, S., Viscidi, R. P., & Roden, R. B. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11152-11160.2004 · Cited by 123
Philpott, N. J., Nociari, M., Elkon, K. B., & Falck-Pedersen, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308368101 · Cited by 122
A comparison of cDNA, oligonucleotide, and Affymetrix GeneChip gene expression microarray platforms.
Woo, Y., Affourtit, J. P., Daigle, S. L., Viale, A. J., Johnson, K., Naggert, J. Κ., & Churchill, G. A. (2004) · PubMed Central · Cited by 121
Tibbles, L. A., Spurrell, J. C. L., Bowen, G. P., Liu, Q., Lam, M., Zaiss, A. K., Robbins, S. M., Hollenberg, M. D., Wickham, T. J., & Muruve, D. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.4.1559-1568.2002 · Cited by 120
Varnavski, A. N., Calcedo, R., Bove, M. S., Gao, G., & Wilson, J. M. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302347 · Cited by 115
Preferential Activation of Toll-Like Receptor Nine by CD46-Utilizing Adenoviruses
Iacobelli-Martinez, M., & Nemerow, G. R. (2006) · Journal of Virology · doi:10.1128/jvi.01926-06 · Cited by 113
Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats
Nicol, C. G., Graham, D., Miller, W. H., White, S. J., Smith, T. A., Nicklin, S. A., Stevenson, S. C., & Baker, A. H. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.020 · Cited by 113
Higginbotham, J. N., Seth, P. K., Blaese, R. M., & Ramsey, W. J. (2002) · Human Gene Therapy · doi:10.1089/10430340152712683 · Cited by 113
Croyle, M. A., Le, H. T., Linse, K. D., Cerullo, V., Toietta, G., Beaudet, A. L., & Pastore, L. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302441 · Cited by 113
Ni, S., Bernt, K. M., Gaggar, A., Li, Z.-Y., Kiem, H., & Lieber, A. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.664 · Cited by 104
Basner‐Tschakarjan, E., Gaffal, E., O’Keeffe, M. A., Tormo, D., Limmer, A., Wagner, H., Hochrein, H., & Tüting, T. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.964 · Cited by 102
Simultaneous CAR- and αV integrin-binding ablation fails to reduce Ad5 liver tropism
Martin, K., Brie, A., Saulnier, P., Perricaudet, M., Yeh, P., & Vigne, E. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00182-5 · Cited by 100
SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection
Harrod, K. S., Trapnell, B. C., Otake, K., Korfhagen, T. R., & Whitsett, J. A. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.277.3.l580 · Cited by 97
Kiang, A., Hartman, Z. C., Everett, R., Serra, D. M., Jiang, H., Frank, M. M., & Amalfitano, A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.024 · Cited by 93
Self-citationTamanini, A., Nicolis, E., Bonizzato, A., Bezzerri, V., Melotti, P., Assael, B. M., & Cabrini, G. (2006) · Journal of Virology · doi:10.1128/jvi.00721-06 · Cited by 91
Bowen, G. P., Borgland, S. L., Lam, M., Libermann, T. A., Wong, N. C. W., & Muruve, D. A. (2002) · Human Gene Therapy · doi:10.1089/10430340252792503 · Cited by 87
Jiang, H., Wang, Z., Serra, D. M., Frank, M. M., & Amalfitano, A. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.015 · Cited by 84
Self-citationHartman, Z. C., Black, E. P., & Amalfitano, A. (2006) · Virology · doi:10.1016/j.virol.2006.08.041 · Cited by 81
Self-citationMurine dendritic cells infected with adenovirus vectors show signs of activation
Hirschowitz, E. A., Weaver, J., Hidalgo, G., & Doherty, D. E. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301210 · Cited by 79
Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity
Kurt‐Jones, E. A., Sandor, F., Ortiz, Y., Bowen, G. N., Counter, S. L., Wang, T. C., & Finberg, R. W. (2004) · Journal of Endotoxin Research · doi:10.1179/096805104225006516 · Cited by 79
Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.
Hensley, S. E., Cun, A. S., Giles-Davis, W., Li, Y., Xiang, Z., Lasaro, M. O., Williams, B. R. G., Silverman, R. H., & Ertl, H. C. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300024 · Cited by 78
Preexisting Immunity to Adenovirus in Rhesus Monkeys Fails To Prevent Vector-Induced Toxicity
Varnavski, A. N., Zhang, Y., Schnell, M. A., Tazelaar, J., Louboutin, J., Yu, Q., Bagg, A., Gao, G., & Wilson, J. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5711-5719.2002 · Cited by 78
Hensley, S. E., Giles‐Davis, W., McCoy, K. C., Weninger, W., & Ertl, H. C. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6032 · Cited by 73
Fiber-Modified Adenovirus Vectors Decrease Liver Toxicity through Reduced IL-6 Production
Koizumi, N., Yamaguchi, T., Kawabata, K., Sakurai, F., Sasaki, T., Watanabe, Y., Hayakawa, T., & Mizuguchi, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1767 · Cited by 72
Role of Viral Vectors and Virion Shells in Cellular Gene Expression
Stilwell, J. L., & Samulski, R. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.007 · Cited by 67
Kritz, A., Nicol, C. G., Dishart, K. L., Nelson, R., Holbeck, S. L., Seggern, D. J. V., Work, L. M., McVey, J. H., Nicklin, S. A., & Baker, A. H. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300094 · Cited by 61
Shayakhmetov, D. M., Li, Z.-Y., Ni, S., & Lieber, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7310 · Cited by 50
Thorne, P. S., McCray, P. B., Howe, T. S., & O'Neill, M. A. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.6.3632 · Cited by 49
Lyakh, L. A., Koski, G. K., Young, H. A., Spence, S. E., Cohen, P. A., & Rice, N. R. (2002) · Blood · doi:10.1182/blood.v99.2.600 · Cited by 48
Malkevitch, N., Patterson, L. J., Aldrich, K., Richardson, E. S., Alvord, W. G., & Robert-Guroff, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4281 · Cited by 47
Effect of Adenovirus Gene Transfer Vectors on the Immunologic Functions of Mouse Dendritic Cells
Korst, R. J., Mahtabifard, A., Yamada, R. E., & Crystal, R. G. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0538 · Cited by 45
Ziegler, R. J., Li, C. Q., Cherry, M., Zhu, Y., Hempel, D. M., van Rooijen, N., Ioannou, Y. A., Desnick, R. J., Goldberg, M. A., Yew, N. S., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340252939041 · Cited by 45
Surfactant Protein A–Polylysine Conjugates for Delivery of DNA to Airway Cells in Culture
Ross, G. F., Morris, R. E., Ciraolo, G. M., Huelsman, K. M., Bruno, M. D., Whitsett, J. A., Baatz, J. E., & Korfhagen, T. R. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.1-31 · Cited by 43
Lipid Emulsions Potently Increase Transgene Expression in Hepatocytes after Adenoviral Transfer
Snoeys, J., Mertens, G., Lievens, J., van Berkel, T. J. C., Collen, D., Biessen, E. A. L., & Geest, B. D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.06.477 · Cited by 42
Granberg, F., Svensson, C., Pettersson, U., & Zhao, H. (2006) · Virology · doi:10.1016/j.virol.2006.06.019 · Cited by 40
Recombinant Adenoviral Vector Disrupts Surfactant Homeostasis in Mouse Lung
Zsengellér, Z. K., Wert, S. E., Bachurski, C. J., Kirwin, K. L., Trapnell, B. C., & Whitsett, J. A. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.11-1331 · Cited by 35
Liu, Q., White, L. R., Clark, S. A., Heffner, D. J., Winston, B. W., Tibbles, L. A., & Muruve, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14507-14515.2005 · Cited by 33
Haberberger, T., Kupfer, K., & Murphy, J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301181 · Cited by 33
Optimization of dendritic cell maturation and gene transfer by recombinant adenovirus
Miller, G., Lahrs, S., Shah, A. B., & DeMatteo, R. P. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0379-6 · Cited by 32
Mouse Mammary Tumor Virus and the Immune System
Czarneski, J., Rassa, J. C., & Ross, S. R. (2003) · Immunologic Research · doi:10.1385/ir:27:2-3:469 · Cited by 29
Faraday, N. R., Rade, J. J., Johns, D. C., Khetawat, G., Noga, S. J., DiPersio, J. F., Jin, Y. S., Nichol, J. L., Haug, J. S., & Bray, P. F. (1999) · Blood · doi:10.1182/blood.v94.12.4084 · Cited by 29
Varnavski, A. N., Schlienger, K., Bergelson, J. M., Gao, G., & Wilson, J. M. (2003) · Human Gene Therapy · doi:10.1089/104303403764539323 · Cited by 26
Identification of Specific Cellular Genes Up-Regulated Late in Adenovirus Type 12 Infection
Dorn, A., Zhao, H., Granberg, F., Hösel, M., Webb, D., Svensson, C., Pettersson, U., & Doerfler, W. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2404-2412.2005 · Cited by 24
Martina, Y., Avitabile, D., Piersanti, S., Cherubini, G., & Saggio, I. (2007) · Virus Research · doi:10.1016/j.virusres.2007.05.019 · Cited by 12
Gillitzer, A., Peluso, M. V., Laugwitz, K., Münch, G., Maßberg, S., Konrad, I., Gawaz, M., & Ungerer, M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000172659.01157.c6 · Cited by 11
Scibetta, A. G., Copier, J. P., Barrett, A. N., Chaplin, T., & Taylor‐Papadimitriou, J. (2005) · Intervirology · doi:10.1159/000086062 · Cited by 11
Tarodi, B., Metz, D. H., Douglas, A., & Russell, W. C. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-3-425 · Cited by 10
Volk, A. L., Rivera, Á. A., Page, G. P., Salazar-Gonzalez, J. F., Nettelbeck, D. M., Matthews, Q. L., & Curiel, D. T. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700776 · Cited by 8
Cited by
Sorted by citations
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Sadarangani, M., Marchant, A., & Kollmann, T. R. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00578-z · Cited by 560
The soil pH and heavy metals revealed their impact on soil microbial community
Naz, M., Dai, Z., Hussain, S., Tariq, M., Danish, S., Khan, I. U., Qi, S., & Du, D. (2022) · Journal of Environmental Management · doi:10.1016/j.jenvman.2022.115770 · Cited by 535
Adenoviruses: update on structure and function
Russell, W. C. (2008) · Journal of General Virology · doi:10.1099/vir.0.003087-0 · Cited by 462
Adenovirus: The First Effective In Vivo Gene Delivery Vector
Crystal, R. G. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.2527 · Cited by 348
Genetically Engineered Microvesicles Carrying Suicide mRNA/Protein Inhibit Schwannoma Tumor Growth
Mizrak, A., Bolukbasi, M. F., Ozdener, G. B., Brenner, G. J., Madlener, S., Erkan, E. P., Ströbel, T., Breakefield, X. O., & Saydam, O. (2013) · Molecular Therapy · doi:10.1038/mt.2012.161 · Cited by 337
Metadata
- Authors
- Hartman, Z. C., Appledorn, D. M., & Amalfitano, A.
- Affiliations
- Duke Medical Center (US)
- Michigan State University (US)
- Corresponding author
- Amalfitano, Andrea
- ORCID
- Hartman, Zachary C.
- Venue
- Virus Research
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 132
- Issue
- 1-2
- Pages
- 1-14
- ISSN
- 0168-1702 (ISSN-L)
- PMC
- PMC4039020
- OpenAlex
- W2075338937
- Cited by
- 239
- References
- 101
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 6 · 2023: 9 · 2022: 6 · 2021: 14 · 2020: 13 · 2019: 8 · 2018: 6 · 2017: 14 · 2016: 3 · 2015: 11 · 2014: 14 · 2013: 17 · 2012: 15
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Virus Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (P01CA078673, CA078673)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK069884, R01DK069884)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- adenoviral vector, innate immune response, gene therapy, vaccine development, adjuvants, immune evasion, gene delivery vectors, vector toxicity
- MeSH terms
- Adenoviridae, Animals, Genetic Vectors, Humans, Immunity, Innate, Receptors, Virus, Viral Vaccines, Genetic Therapy, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review